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Vitamin D status is associated with early markers 
of cardiovascular disease in prepubertal children
Abstract
Background: The associations of 25-hydroxyvitamin D 
[25(OH)D], non-high-density lipoprotein (HDL) choles-
terol, low-density lipoprotein (LDL), and related markers 
of early cardiovascular disease (CVD) are unclear in pre-
pubertal children.
Objective: To investigate the association of 25(OH)D with 
markers of CVD. The hypothesis was that 25(OH)D would 
vary inversely with non-HDL-C.
Subjects and methods: A prospective cross-sectional 
study of children (n = 45; 26 males, 19 females) of mean 
age 8.3 ± 2.5 years to investigate the relationships between 
25(OH)D and glucose, insulin, high-sensitivity C-reactive 
protein, and lipids. Vitamin D deficiency was defined 
as 25(OH)D  < 20 ng/mL; overweight as body mass 
index (BMI)  ≥  85th but  < 95th percentile; and obesity as 
BMI  > 95th percentile.
Results: Twenty subjects (44.4%) had BMI  < 85%, and 25 
had BMI of  ≥ 85%. Eleven participants (24.4%) had 25(OH)
D of  < 20 ng/mL, and 10 (22.2%) had 25(OH)D of  > 30 ng/mL. 
Patients with 25(OH)D of  < 20 ng/mL had significantly ele-
vated non-HDL-C (136.08 ± 44.66 vs. 109.88 ± 28.25, p = 0.025), 
total cholesterol (TC)/HDL ratio (3.89 ± 1.20 vs. 3.21 ± 0.83, 
p = 0.042), and triglycerides (TG) (117.09 ± 71.27 vs. 73.39 ± 46.53, 
p = 0.024), while those with 25(OH)D of  > 30 ng/mL had signif-
icantly lower non-HDL-C, TC/HDL, TG, and LDL (82.40 ± 18.03 
vs. 105.15 ± 28.38, p = 0.006). Multivariate analysis showed sig-
nificant inverse correlations between 25(OH)D and non-HDL 
cholesterol (β = –0.337, p = 0.043), and TC/HDL ratio (β = –0.339, 
p = 0.028), and LDL (β = –0.359, p = 0.016), after adjusting for 
age, race, sex, BMI, and seasonality.
Conclusions: Vitamin D varied inversely with non-HDL, 
TC/HDL, and LDL. A 25(OH)D level of 30 ng/mL is associ-
ated with optimal cardioprotection in children.
Keywords: cardiovascular disease; prepubertal children; 
vitamin D status.
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Introduction
Several studies have reported a link between vitamin D 
deficiency and cardiometabolic risk factors such as inflam-
mation, insulin resistance, abnormal lipid profile, and high 
blood pressure in adults (1–4). Few studies, however, have 
investigated these relationships in prepubertal children 
(5, 6). Most of the pediatric studies were either conducted 
in older children and adolescents exclusively or in a mixed 
group of children and adolescents (7–9). For example, 
data from the 2001–2004 National Health and Nutri-
tion Examination Surveys (NHANES) analysis reported 
that 25-hydroxyvitamin D [25(OH)D] concentrations were 
inversely associated with systolic blood pressure (BP) and 
plasma glucose concentrations in 3577 youth of 12–19 years 
(10), while a second report on the same data in 6257 chil-
dren and adolescents of ages 1–21 years showed that 25(OH)
D level of  < 15 ng/mL was associated with increased BP and 
lower high-density lipoprotein (HDL) cholesterol (8). A 
third report on 5867 adolescents of ages 12–19 years using 
three cycles of NHANES data from 2001 through 2006 found 
that serum 25(OH)D level was related to homeostasis 
model assessment-insulin resistance index (HOMA-IR), sys-
tolic blood pressure (SBP), and HDL cholesterol, but not to 
high-sensitivity C-reactive protein (hsCRP) (9). A study of 
701 adolescents of ages 14–18 years living in the sunny parts 
of the US showed significant inverse correlations between 
serum 25(OH)D concentrations and leptin, fibrinogen, 
glucose, HOMA-IR, SBP, and diastolic blood pressure (DBP), 
and significant positive correlations between adiponectin 
and HDL cholesterol (6). Another study (11) evaluated the 
relationship between vitamin D status, total and abdominal 
adiposity, and lipids in 237 preadolescent and adolescent 
black and white subjects of ages 8–18 years and found that 
lower levels of 25(OH)D were associated with higher adi-
posity measures and lower HDL cholesterol levels. A recent 
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study (5) from the UK examined the differential associa-
tions of each of the 25(OH)D metabolites, namely, 25(OH)D2 
and 25(OH)D3, with cardiovascular risk factors in 4274 pre-
pubertal children of mean age of 9.9 years and, surprisingly, 
found that lower 25(OH)D2 status was associated with lower 
levels of chronic inflammatory markers – CRP and interleu-
kin-6 – and higher levels of apolipoprotein A1. In contrast, 
higher circulating 25(OH)D3 was associated with elevated 
levels of HDL cholesterol, apolipoprotein A1, and adi-
ponectin. There was no evidence for associations of either 
25(OH)D2 or 25(OH)D3 with DBP or low-density lipoprotein 
(LDL) cholesterol. The mixed results from this study made it 
rather difficult to accurately characterize the relationships 
of vitamin D and cardiovascular risk factors in prepubertal 
children.
Although the above studies have provided useful 
information to advance the field, there are some vital 
areas that need to be addressed to effectively determine 
the exact relationship between vitamin D and cardiometa-
bolic risks in prepubertal children. Given the mixed find-
ings from the only exclusively preadolescent study above 
(5), the relationship between vitamin D status and markers 
of cardiovascular disease in prepubertal children remains 
unclear. Furthermore, because the rest of the studies were 
either performed exclusively in adolescents (6, 9, 10) or in 
a mixed group of children and adolescents (8, 11), the role 
of pubertal hormonal fluctuations and body fat changes on 
the findings of these studies is unclear. In order to exclude 
the influence of such confounders and determine the exact 
nature of the relationship between vitamin D and cardio-
metabolic risk factors, it is necessary to conduct such a 
study in a cohort of healthy prepubertal children.
Another important reason to conduct this study in 
an exclusive cohort of prepubertal children was to evalu-
ate the recent report from the Expert Panel on Integrated 
Guidelines for Cardiovascular Health and Risk Reduction 
in Children and Adolescents which recommends that all 
prepubertal children be screened for risk factors of car-
diovascular disease (CVD) (12) using non-HDL cholesterol 
as a core screening tool for the identification of dyslipi-
demia in childhood (12). Non-HDL cholesterol is defined 
as the difference between TC and HDL cholesterol and, 
thus, represents cholesterol carried on all of the poten-
tially proatherogenic apoB-containing particles [primar-
ily very low density lipoprotein, intermediate-density 
lipoprotein, and LDL, as well as chylomicron remnants 
and lipoprotein(a)] (13). It is a significant predictor of ath-
erosclerosis and future cardiovascular events compared 
to TC, LDL-cholesterol, or HDL-cholesterol levels alone 
(12, 14). However, the relationship between vitamin D 
and non-HDL cholesterol in prepubertal children has not 
been adequately studied. Our primary aim was to deter-
mine the association of serum 25(OH)D concentrations 
with non-HDL cholesterol and related cardiometabolic 
risk factors in healthy prepubertal children. Our primary 
hypothesis was that non-HDL cholesterol would vary 
inversely with the serum concentrations of total body 
vitamin D as measured by 25(OH)D level.
Subjects and methods
The study protocol was approved by the University of Massachusetts 
Institutional Review Board. The study’s clinical trial identification 
number is NCT00756899. Written informed consent was obtained 
from each subject’s parent or legal guardian, and assent was ob-
tained from each subject prior to participating in the study.
Subjects
All participants were healthy children who were recruited by means 
of advertisement using paper flyers distributed to the primary care 
physician offices in Central New England, USA. Fifty subjects signed 
consent for the study. Four patients failed to return for the study. 
One patient developed needle phobia after initial assessment and 
refused phlebotomy. Forty-five subjects (26 males and 19 females) 
between 3 and 12  years of age were studied. The mean age of the 
cohort was 8.3 ± 2.5 years, while the mean age of the females was 
7.28 ± 2.4 years, and the mean age of the males was 9.0 ± 2.4 years. All 
participants were of prepubertal status: males, with testicular vol-
ume of  ≤  3 mL, and females, with Tanner 1 breasts as determined 
by the principal investigator. Subjects were excluded if they had any 
known metabolic or genetic diseases resulting in obesity such as se-
vere hypothyroidism, pseudohypoparathyroidism, or Cushing’s dis-
ease. We also excluded patients with known familial dyslipidemias 
and secondary causes of dyslipidemia such as diabetes mellitus, 
nephrotic syndrome, chronic renal disease, history of Kawasaki 
disease, and chronic inflammatory disorders. Subjects were also ex-
cluded if they were receiving lipid-lowering medications or taking 
medications known to impact body weight or calcium homeostasis. 
Subjects with a history of significant weight loss or gain (change 
of  > 10% body weight in 6 months) were excluded from the study. 
Methods used for exclusion included history, physical examination, 
and screening laboratory tests for fasting blood glucose, cortisol, 
urinalysis, comprehensive metabolic panel, serum creatinine, and 
thyroid function tests. Because vitamin D status could vary with 
sunlight exposure and the seasons, we categorized each subject’s 
visit according to the seasons as follows: fall (September 22–Decem-
ber 21), winter (December 22–March 21), spring (March 22–June 21), 
and summer (June 22–September 21) (15).
Study methods
All participants in this cross-sectional study were evaluated at the 
UMass Memorial Children’s Medical Center between 0800 and 
0900 h following an overnight fast.
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Anthropometry
Height was measured to the nearest 0.1 cm using a wall-mounted sta-
diometer (Holtain Ltd., Crymych, Dyfed, UK). Weight was measured 
to the nearest 0.1 kg using an upright scale. Body mass index (BMI) 
was derived using the formula weight in kilograms divided by the 
square of the height in meters (kg/m2) and expressed as standard de-
viation score (SDS) for age and gender based on National Center for 
Health Statistics standards (16).
Biochemical studies
Fasting blood sample was collected for the following analytes: glu-
cose, insulin, 25(OH)D, lipid profile, and hsCRP. All samples were 
centrifuged and stored at –70°C until assay.
Assay
Serum levels of 25(OH)D were analyzed using 25-hydroxy chemilu-
minescent immunoassay (DiaSorin Liaison; Stillwater, MN, USA), 
which has a 100% cross-reactivity with both metabolites of 25(OH)D, 
namely, 25(OH)D2 and 25(OH)D3, and thus measures total serum 
25(OH)D content. Its functional sensitivity is 4 ng/mL, and its intra- 
and inter-assay coefficients of variation are 5% and 8.2%, respective-
ly. Vitamin D status was classified according to American Academy of 
Pediatrics and the Institutes of Medicine criteria as deficient [25(OH)
D  < 20 ng/mL] or sufficient [25(OH)D  > 20 ng/mL] (17).
Lipid levels were measured enzymatically on a Hitachi 917 ana-
lyzer (Roche Diagnostics, Indianapolis, IN, USA) using reagents and 
calibrators from Roche Diagnostics in a laboratory certified by the 
Centers for Disease Control and Prevention/National Heart, Lung, 
and Blood Institute’s Lipid Standardization Program (17). Non-HDL 
cholesterol was calculated by subtracting HDL cholesterol from total 
cholesterol (14).
Serum hsCRP was measured by a latex particle-enhanced im-
mune-turbidimetric immunoassay (Immulite 1000 High-Sensitivity 
CRP, Diagnostic Products, Los Angeles, CA, USA). The minimal de-
tected CRP level was 0.01 mg/L, with intra-assay and interassay CV of 
4.2%–6.4% and 4.9%–10.0%, respectively (17).
Insulin was measured by microparticle-enhanced immuno-
metric assay (Abbott, Wiesbaden, Germany), and glucose on a Vit-
ros analyzer (Ortho Clinical Diagnostics, Neckargemünd, Germany). 
Insulin resistance was estimated from fasting plasma measurements 
using the homeostasis model of insulin resistance (HOMA-IR) [insu-
lin (mU/L) × glucose (mmol/L)/22.5] (9).
Statistical analyses
Statistical analyses were performed using SPSS v. 20 (IBM Corpora-
tion, Somers, NY, USA). Means, standard deviations, and percentages 
were calculated for descriptive summary statistics. The values for 
25(OH)D, non-HDL cholesterol, cholesterol/HDL ratio, and HOMA-IR 
were logarithmically transformed to approximate normal distribu-
tions. Univariate comparisons between groups were made using the 
Student’s t-test. Data were expressed as mean ± standard deviation. 
Proportions were compared using Fisher’s exact test. Simple and 
multiple linear regression models were specified to describe the re-
lationships between the parameters of interest. For the analysis of 
seasonality, data on the seasons associated with high 25(OH)D levels 
(summer and fall) were combined and contrasted with the seasons 
with lower 25(OH)D levels (winter and spring) based on an earlier re-
port by Ostergard et al. (18), which demonstrated a significant season-
al difference in 25(OH)D, with higher levels during summer-autumn 
compared with winter-spring (p = 0.021) after controlling for BMI.
Results
Subjects were first categorized into vitamin D-deficient 
[25(OH)D level of  < 20 ng/mL] and vitamin D-sufficient 
[25(OH)D of  > 20 ng/mL] groups (Table 1) (19). Table 1 
shows the mean ( ± SD) values for age, gender, seasona lity, 
anthropometric, and biochemical parameters. Subjects 
with vitamin D deficiency had significantly elevated values 
for non-HDL cholesterol, TC/HDL ratio, and triglycerides 
(TG). There were no significant differences between the 
groups for systolic or diastolic blood pressure, LDL cho-
lesterol, and hsCRP. Further analysis showed a significant 
positive correlation between 25(OH)D and HDL cholesterol, 
and significant inverse correlations between 25(OH)D and 
HOMA-IR, non-HDL cholesterol, LDL, and TC/HDL ratio. 
However, only the relationships between 25(OH)D and LDL 
(β = –0.359, p = 0.016), non-HDL cholesterol (Figure 1), and 
TC/HDL ratio (Figure 2) remained significant after adjust-
ing for age, sex, race, BMI, and seasonality.
Further analysis showed that 22.2% of the subjects 
had 25(OH)D levels  ≥  30 ng/mL. Participants with 25(OH)
D level of  ≥  30 ng/mL had a significant reduction in LDL 
cholesterol (82.40 ± 18.03 vs. 105.15 ± 28.38, p = 0.006) and 
in all the lipid parameters that were significantly lower 
at a 25(OH)D cut-off value of 20 ng/mL, viz, triglycer-
ides (61.1 ± 27.41 vs. 89.84 ± 61.29, p = 0.044), TC/HDL ratio 
(2.72 ± 0.52 vs. 3.56 ± 0.99, p = 0.001), and non-HDL chole-
sterol (94.60 ± 16.55 vs. 123.12 ± 36.84, p = 0.002).
In subsequent analysis, the subjects were stratified 
into normal-weight vs. overweight and obese groups to 
determine the influence of obesity on the CVD parameters 
(Table 2). Overweight was defined as body mass index 
(BMI) of  ≥  85th but  < 95th percentile, while obesity was 
defined as a BMI of  ≥  95th percentile for age and sex. The 
overweight/obese prepubertal children had significantly 
lower levels of 25(OH)D and HDL cholesterol, but signifi-
cantly elevated values for hsCRP, total cholesterol (TC)/
HDL ratio, triglycerides, non-HDL, systolic blood pressure, 
and diastolic blood pressure. There was no difference in 
the level of LDL cholesterol between the normal-weight 
and overweight/obese groups.
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Table 1 Physical and biochemical characteristics of subjects stratified by vitamin D status.
Parameters 25(OH)D  ≤  20 ng/dL 25(OH)D  > 20 ng/dL p-Valuea
n 11 34
Age, years 8.72 ± 2.48 8.16 ± 2.58 0.534
Sex, males 3 13 0.720
Race, white 9 (81.8%) 30 (88.2%) 0.841
Weight, kg 47.78 ± 25.43 36.48 ± 20.61 0.143
Height, cm 131.47 ± 15.0 127.51 ± 17.59 0.505
BMI SDS 1.67 ± 1.01 0.90 ± 1.55 0.133
SBP, mm Hg 105.55 ± 9.47 103.88 ± 14.37 0.722
DBP, mm Hg 65.27 ± 8.34 61.18 ± 9.55 0.228
25(OH)D, ng/mL 16.82 ± 3.71 29.88 ± 9.92  < 0.001
hsCRP, mg/mL 2.28 ± 1.58 1.55 ± 1.29 0.134
Total cholesterol (TC), mg/dL 185.18 ± 43.86 163.91 ± 27.36 0.064
Triglycerides, mg/dL 117.09 ± 71.27 73.39 ± 46.53 0.024
HDL-cholesterol, mg/dL 49.45 ± 7.27 53.12 ± 11.38 0.324
LDL-cholesterol, mg/dL 112.27 ± 37.39 96.12 ± 22.85 0.093
TC/DL ratio 3.89 ± 1.20 3.21 ± 0.83 0.042
Non-HDL cholesterol, mg/dL 136.08 ± 44.66 109.88 ± 28.25 0.025
Fasting blood glucose, mg/dL 88.64 ± 7.61 85.39 ± 6.56 0.236
Insulin, μU/mL 10.70 ± 8.27 7.48 ± 8.04 0.302
HOMA-IR 2.27 ± 2.12 1.62 ± 1.81 0.423
Season (summer-fall) 3 11 1.0
BMI, Body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; 25(OH)D, 25-hydroxyvitamin D; hsCRP, high sensitivity 
C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin 
resistance. aResults for two tailed t-tests. Significant t-tests are italicized.
Discussion
In summary, these data showed significantly elevated 
levels of non-HDL cholesterol, triglycerides, and TC/HDL 
ratio in prepubertal children with serum 25(OH)D level 
of  < 20 ng/mL. There were significant inverse correlations 
between 25(OH)D and non-HDL cholesterol, LDL, and TC/
HDL ratio in all patients when adjusted for age, sex, race, 
BMI, and seasonality. When compared to normal-weight 
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Figure 2 The relationship between 25-hydroxyvitamin D and total 
cholesterol/HDL ratio in prepubertal children. This inverse correla-
tion remained significant after adjusting for body mass index, age, 
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Figure 1 The relationship between 25-hydroxyvitamin D and 
non-HDL cholesterol in prepubertal children. This inverse correla-
tion remained significant after adjusting for body mass index, age, 
sex, race, and seasonality.
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Table 2 Physical and biochemical characteristics of subjects stratified by body mass index.
Parameters Normal weight (BMI  < 85%) Overweight/obese (BMI  ≥  85%) p-Valuea
n 20 25
Age, years 7.45 ± 2.36 8.98 ± 2.51 0.042
Sex, males 11 15 0.770
Race, white 18 (90%) 21 (84%) 0.710
Weight, kg 22.00 ± 5.17 53.04 ± 20.75  < 0.001
Height, cm 117.73 ± 10.35 137.07 ± 16.32  < 0.001
BMI, SDS –0.27 ± 1.03 2.18 ± 0.56  < 0.001
SBP, mm Hg 96.73 ± 6.85 110.04 ± 14.09  < 0.001
DBP, mm Hg 57.80 ± 6.36 65.56 ± 9.95 0.003
25OHD, ng/mL 30.90 ± 13.22 23.04 ± 5.51 0.020
CRP, ng/mL (median) 1.06 ± 0.17 2.30 ± 1.68 0.001
Total cholesterol, mg/dL 160.70 ± 26.70 176.33 ± 36.54 0.109
Triglycerides, mg/dL 60.70 ± 28.44 104.00 ± 65.94 0.007
HDL, mg/dL 56.35 ± 10.19 48.75 ± 9.73 0.016
LDL, mg/dL 92.20 ± 23.85 106.79 ± 29.27 0.076
TC/DL ratio 2.95 ± 0.72 3.74 ± 1.00 0.004
Non-HDL cholesterol, mg/dL 104.35 ± 28.07 127.58 ± 37.20 0.027
Fasting blood glucose, mg/dL 83.72 ± 6.62 88.13 ± 6.63 0.040
Insulin, μU/mL 2.75 ± 1.48 12.17 ± 8.61  < 0.001
HOMA-IR 0.58 ± 0.35 2.71 ± 2.03  < 0.001
Season (summer-fall) 5 9 0.525
aResults for two-tailed t-tests. Significant t-tests are italicized.
significantly lower HDL cholesterol and 25(OH)D levels, 
but significantly elevated levels for hsCRP, TC/HDL ratio, 
non-HDL cholesterol, triglycerides, HOMA-IR, and blood 
pressure. Children with 25(OH)D level of  ≥  30 ng/mL had 
significantly reduced LDL cholesterol level in addition to 
the other lipid parameters. These findings are detailed 
below.
Cholesterol
Although several studies have established that high BMI 
in children and adolescents is associated with adverse 
levels of lipids, insulin, and blood pressure (20–22), the 
independent associations of vitamin D status with these 
markers of cardiovascular disease in a cohort of prepu-
bertal children have not been adequately studied (17, 
23). Such studies are necessary to evaluate the recent 
summary report from the Expert Panel on Integrated 
Guidelines for Cardiovascular Health and Risk Reduction 
in Children and Adolescents which recommends that all 
prepubertal children be screened for risk factors of cardio-
vascular disease (CVD) (12). The central focus of this rec-
ommendation, which has drawn sharp criticisms (24) 
from some clinicians and praise from others (25), is the 
early initiation of primordial prevention of CVD starting 
in the prepubertal years. Primordial prevention is a term 
that describes the avoidance of risk-factor development, 
in contrast to primary prevention which is the preven-
tion of future CVD by effective management of identified 
risk factors (12). The strong emphasis on the prepubertal 
period stemmed from studies showing that the pathologic 
process of atherosclerotic CVD (2) begins in childhood 
with the deposition of fatty streaks within the arterial 
walls and subsequent progression into fibrous plaques 
throughout adolescence and early adulthood (25). While 
the centerpiece of primordial prevention is lifestyle modi-
fication (26), adherence is poor (27). Hence, the necessity 
to identify modifiable risk factors that could augment 
the primordial prevention of cardiometabolic risk factors 
in prepubertal children. The expert panel based its rec-
ommendation that children be screened for risk factors 
for CVD before the onset of puberty on the finding that 
TC and LDL-cholesterol levels decreased by as much 
as 10%–20% or more during puberty (12). They recom-
mended that 10 years of age (range: 9–11 years) is a stable 
time for lipid assessment in children based on the above-
stated normal pattern of change in lipid and lipoprotein 
levels with growth and maturation (12). The panel recom-
mended the use of non-HDL cholesterol as a key screen-
ing tool for the identification of dyslipidemia in childhood 
because non-HDL cholesterol is a strong predictor of the 
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presence of atherosclerosis in children and adolescents 
(12). A major advantage of non-HDL cholesterol is that it 
can be accurately calculated in a non-fasting state and is 
therefore practical to obtain in routine, regular evalua-
tion of patients (12). While the data showed that there was 
neither a significant difference in LDL cholesterol between 
the normal-weight and overweight/obese groups, nor 
between the vitamin D-deficient and the vitamin D-suffi-
cient groups using a cut-off value of  < 20 ng/mL to define 
vitamin D deficiency, there was a significant difference in 
LDL-cholesterol level when a cut-off value of  > 30 ng/mL 
was used. Further analysis showed that prepubertal chil-
dren with either a 25(OH)D level of  < 20 ng/mL or a BMI 
of  ≥  85th percentile had a significantly higher level of 
non-HDL cholesterol level compared to those with either a 
25(OH)D level of  > 20 ng/mL or a BMI of  < 85th percentile. 
Taken together, our data suggest that the beneficial effects 
of vitamin D on TG, TC/HDL ratio, and non-HDL chole-
sterol are apparent at a 25(OH)D level of 20 ng/mL, while 
the beneficial effects of vitamin D on LDL cholesterol are 
apparent at a much higher level of 30 ng/mL.
The postulated mechanism for the significant reduc-
tion in non-HDL cholesterol and TG levels in vitamin 
D-sufficient subjects is based on the actions of vitamin 
D to improve insulin sensitivity (28) and reduce free fatty 
acid (FFA) generation (29). In general, insulin resistance 
or defects in FFA incorporation into adipocytes lead to 
increased mobilization of FFA to the liver, leading to 
increased TG formation, decreased LDL proteolysis, and 
enhanced very low density lipoprotein production and 
secretion (30). These processes result in elevated serum 
concentrations of non-HDL cholesterol and TG. Vitamin 
D improves insulin sensitivity and limits FFA generation, 
thus leading to reduced serum concentrations of both 
non-HDL cholesterol and TG. The significant reduction in 
25(OH)D level in obese subjects is believed to be primarily 
due to the sequestration of vitamin D in fat depots (31). 
Therefore, in clinical practice, adequate vitamin D sup-
plementation may be necessary to maintain normal serum 
concentrations of non-HDL cholesterol in obese patients.
High-sensitivity C-reactive protein
Recent reports indicate that elevated levels of baseline 
hsCRP, a marker of inflammatory state, are independently 
associated with carotid artery intima-media thickness 
progression, which is a measure of preclinical atheroscle-
rosis (32). CRP is produced in the liver and its concentra-
tion could be increased by malignancy and infections that 
show no relationship to atherosclerosis (32). The proposed 
mechanisms by which hsCRP may play a causal role in 
the atherosclerotic process and CVD include recruit-
ment of monocytes to the atherosclerotic lesion (33), 
intimal growth (34), and endothelial dysfunction (35, 36). 
Our data showed a significantly elevated hsCRP level in 
obese prepubertal children compared to their non-obese 
peers. There was no significant difference in hsCRP level 
between the vitamin D-deficient and -sufficient children. 
Our finding is similar to other reports (5, 6) but differed 
from that of Sacheck et al. (17) who found an association 
between 25(OH)D and hsCRP in a mixed cohort of puber-
tal and postpubertal children and adolescents. A recent 
study (23) reported a high prevalence of vitamin D insuf-
ficiency in severely obese children with elevated levels of 
markers of oxidative/nitrosative stress, inflammation, and 
endothelial activation, such as soluble vascular cell adhe-
sion molecule 1, plasma malondialdehyde, myeloper-
oxidase activity, and interleukin-6, but low levels of HDL 
cholesterol and apolipoprotein A1. These findings suggest 
a link between vitamin D deficiency and the pathogenic 
factors involved in the initiation and propagation of ath-
erosclerosis. Thus, even though the traditional cardiovas-
cular risk factors for atherosclerosis are well known (37, 
38), increasing evidence implicates inflammation in the 
pathogenesis of atherosclerosis and CVD (32). The coexist-
ence of vitamin D deficiency and elevated hsCRP in obese 
children in our study calls for interventional trials to 
examine the role of vitamin D supplementation on hsCRP 
levels in obese children.
Blood pressure
There was no significant difference in blood pressure 
between vitamin D-deficient and vitamin D-sufficient 
prepubertal children. However, the obese prepubertal 
children had significantly elevated SBP and DBP when 
compared to their normal-weight peers. These results 
are similar to the findings by Williams et  al. (5) who 
reported no association between 25(OH)D and SBP or 
DBP. However, other studies (8–10) showed a negative cor-
relation between 25(OH)D and BP in children and adole-
scents. Although the association between low levels of 
25(OH)D and hypertension is well documented in cross-
sectional studies, the evidence is not so strong in prospec-
tive studies (39, 40). Vitamin D is believed to affect blood 
pressure (BP) through several mechanisms such as the 
up-regulation of the renin-angiotensin system in vitamin 
D-deficient states (41, 42), the suppression of parathyroid 
hormone activity (40), and direct modulatory effects on 
vascular smooth muscle cells (43) as many cells that are 
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important for cardiovascular health express the vitamin D 
receptor and respond to calcitriol (44).
Insulin resistance
There was a significant inverse correlation between 25(OH)
D and HOMA-IR, a marker of insulin resistance, in our 
cohort of prepubertal children prior to adjustment for 
covariates. This is consistent with published reports (6, 9) 
except that the associations persisted after adjusting for 
covariates. Although insulin resistance is not part of the 
diagnostic criteria for metabolic syndrome, it is a major car-
diometabolic risk factor associated with the metabolic syn-
drome (45). The mechanisms for the association between 
25(OH)D and insulin resistance are not fully known, but 
one hypothesis is that 25(OH)D promotes insulin sensitiv-
ity (28) through insulin-receptor expression and the regu-
lation of intracellular calcium (46). It is also believed that 
parathyroid hormone could mediate the effects of vitamin 
D on insulin sensitivity and glucose tolerance (47).
Strengths and weaknesses
This study has some limitations. First, the cross-sec-
tional study design excluded causal inference about 
the effects of low vitamin status on cardiovascular risk 
factors in prepubertal children. This study also had a 
small sample size which could have precluded the detec-
tion of subtle differences between the groups. The parti-
cipants were primarily made up of non-Hispanic white 
children. Therefore, our findings may not be generalized 
to other racial groups. We did not measure serum con-
centrations of parathyroid hormone which is believed to 
mediate some of the effects of vitamin D on insulin sensi-
tivity and glucose tolerance (47). We did not measure the 
effect of seasons on the degree of physical activity of the 
children either as this could have impacted the results of 
our findings. It is known that sun exposure is associated 
with increased outdoor physical activity which could 
improve insulin sensitivity independent of serum 25(OH)
D concentrations (46).
The unique strength of this study is that it was con-
ducted exclusively in healthy prepubertal children. When 
compared with studies in adults, associations in chil-
dren are less prone to confounding lifestyle factors, such 
as smoking and alcohol consumption, and are also less 
likely to be biased by the effects of existing medical con-
ditions and their treatments on both 25(OH)D status and 
cardiovascular risk (5). Thus, studies in children permit 
the assessment of potential associations of vitamin D 
with cardiovascular risk than studies in adults. Addition-
ally, studies in prepubertal children exclude the effects of 
pubertal sex steroids on 25(OH)D status and cardiovascu-
lar risks. Furthermore, the blood samples were collected 
throughout all seasons of the year, and all outcomes of 
interest were adjusted for seasons.
Conclusions
This study showed that prepubertal children with 25(OH)
D level of  > 20 ng/mL but  < 30 ng/mL had significantly 
lower levels of non-HDL cholesterol, TC/HDL ratio, and 
TG only, while those with 25(OH)D of  ≥  30 ng/mL had sig-
nificantly reduced levels of non-HDL, TC/HDL, TG, and 
LDL cholesterol. Therefore, a 25(OH)D level of 30 ng/mL, 
not 20 ng/mL, is associated with optimal cardioprotec-
tion in healthy prepubertal children. Non-HDL choles-
terol, LDL, and TC/HDL ratio varied inversely with 25(OH)
D in all subjects after adjusting for covariates. This study 
provides preliminary association data for considering 
larger prospective trials on the possible role of vitamin D 
supplementation in the primordial prevention of CVD.
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